Dosidal · Switzerland

Reblozyl, Pulver zur Herstellung einer Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69592 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69592
atc: B03XA06
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2026-05-21
term: zugelassen
valid_until: 2031-05-20
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B03XA06
authorisation_number: 69592
form: PULVL
holder: Bristol-Myers Squibb SA
holder_partner_nr: 1100488
it_number: 06.07.3.
name: Reblozyl, Pulver zur Herstellung einer Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
MTr5G8Vwtzt-bs3QyC7SENffkF1SHUCjxZtbmAgx4kp5edfoKXmuzl65P-fdmAJVDklZjl12BYR9tU_brCz27g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal